Blog

OncoSec Medical to Present at 3rd Annual Cancer Immunotherapy Conference

SAN DIEGO, CA, October 2, 2012 — OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapies to treat solid tumor cancers, announced today that the company will be presenting at the 3rd Annual Cancer Immunotherapy: A Long-Awaited Reality conference taking place from 8:00 a.m. to 6:30 p.m. EDT on October 4, 2012, at the New York Academy of Medicine in New York.

Punit Dhillon, President and CEO, will provide an overview of ImmunoPulse, a treatment that uses OncoSec’s patented electroporation platform to dramatically enhance the delivery and uptake of a locally delivered DNA-based immunocytokine.

The presentation is expected to begin at 9:15AM ET.

A live and archived webcast of the company’s presentation at the conference hosted by MD Becker Partners LLC will be available at www.regonline.com/mdb2012.

About the 3rd Annual Cancer Immunotherapy: A Long-Awaited Reality Conference

“Cancer Immunotherapy: A Long Awaited Reality” is a unique, single-day conference event that unites founding visionary researchers, clinicians, business leaders, key investors, and other stakeholders to engage in discussions, exchange information, highlight opportunities, and showcase leading companies in the field of cancer immunotherapy.

 

 

OncoSec to Present at Upcoming Healthcare and Investor Conferences

CEO Punit Dhillon Will Present at BIOX, Cancer Immunotherapy and IN3 Device Conferences and Participate at Burrill and Cowen Conferences

SAN DIEGO – September 20, 2012 — OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that Punit Dhillon, President and CEO, will present at the following healthcare and investor conferences in upcoming weeks:

– Noble Financial BioXposition (BIOX), University of Connecticut, Stamford Campus, Stamford, CT, September 24 at 4:00 PM ET

– MD Becker Third Annual “Cancer Immunotherapy: A Long Awaited Reality” Conference, New York Academy of Medicine, New York, NY, October 4 at 9:15 AM ET

– Investment in Innovation (IN3) Medical Device 360° Summit, Intercontinental Mark Hopkins, San Francisco, CA, October 16 at 10:30 AM PT

In addition, Mr. Dhillon will attend the exclusive Burrill & Company Biotech Meeting in Laguna Beach, CA on October 7-9 and the Cowen Group 15th Annual Therapeutics Conference in New York, NY on October 10.

Following the Noble Financial and MD Becker events, a video webcast of the presentations can be viewed on OncoSec’s website at: http://oncosec.com/index.php/press-media/events-media/